GMED Insider Activity (SEC Form 4)

GMED 
$23.04
*  
0.11
 negative 
0.48%
Get GMED Alerts
*Delayed - data as of Apr. 16, 2014 
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    GMED After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time

Sales Activity

Insider Summary

Type Last 3 Mo. Last 12 Mo.
Number of Insider Trades 5 44
Number of Open Market Buys
View: All Purchases
5
Number of Sells 5 39
Net Activity (421,329) (22,842,608)
Total Shares Traded: 421,329 24,049,352
Number of Shares Bought: 603,372
Number of Shares Sold: 421,329 23,445,980

Insider Trading information for GMED is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Learn more about the information on this page in the help area for Insider Trades.

Trades in last 3 months: 5
Trades in last 12 months: 44
The Summary totals only include Open Market Buys, the table below Includes all purchases.

Click on the column header links to resort ascending (▲) or descending (▼).
Insider Relation ▲ Last Date Transaction Type OwnerType Shares Traded Last Price Shares Held
CLARUS LIFESCIENCES I, L.P. Beneficial Owner (10%) 08/08/2012 Acquisition (Non Open Market) indirect 7,444,168 0.0000 8,048,433
CLARUS LIFESCIENCES I, L.P. Beneficial Owner (10%) 08/08/2012 Sell indirect 804,232 11.1600 7,244,201
GOLDMAN SACHS GROUP INC Beneficial Owner (10%) 08/08/2012 Acquisition (Non Open Market) indirect 7,089,681 7,643,526
GOLDMAN SACHS PRIVATE EQUITY PARTNERS 2004 OFFSHORE HOLDINGS Beneficial Owner (10%) 08/08/2012 Acquisition (Non Open Market) indirect 7,089,681 7,643,526
CLARUS LIFESCIENCES I, L.P. Beneficial Owner (10%) 09/03/2013 Disposition (Non Open Market) indirect 7,244,201 0.0000
LIPTAK ROBERT Director 08/08/2012 Acquisition (Non Open Market) indirect 7,444,168 0.0000 8,048,433
LIPTAK ROBERT Director 08/08/2012 Sell indirect 804,232 11.1600 7,244,201
WHEELER KURT Director 08/08/2012 Acquisition (Non Open Market) indirect 7,444,168 0.0000 8,048,433
WHEELER KURT Director 08/08/2012 Sell indirect 804,232 11.1600 7,244,201
DAVIDAR DAVID D Director 04/22/2013 Disposition (Non Open Market) indirect 465,894 0.0000
DAVIDAR DAVID D Director 04/22/2013 Acquisition (Non Open Market) direct 104,927 0.0000 1,142,275
DAVIDAR DAVID D Director 04/22/2013 Acquisition (Non Open Market) indirect 360,967 0.0000 360,967
DAVIDAR DAVID D Director 05/08/2013 Disposition (Non Open Market) direct 35,000 0.0000 1,107,275
DAVIDAR DAVID D Director 05/08/2013 Acquisition (Non Open Market) indirect 35,000 0.0000 35,000
LIPTAK ROBERT Director 09/03/2013 Disposition (Non Open Market) indirect 7,244,201 0.0000